Evaluation of Syndecan-1 as a Novel Biomarker for Adverse Pregnancy Outcomes

Circulating Angiogenic Factors and the Risk of Preeclampsia

Richard J. Levine, Cong Qian, Lucinda J. England et al. · New England Journal of Medicine · 2004 · 3.6K citations · Full text

Public Health, Maternal Health, Obstetrics +11

Circulating angiogenic factors and the risk of preeclampsia*

Obstetrics and Gynecology · 2004 · 2.6K citations

Medicine, Gynecology, Obstetrics +14

ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy

Obstetrics and Gynecology · 2018 · 675 citations

Medicine, Obstetrics, Pharmacotherapy +15

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

N. O’Gorman, D. Wright, Argyro Syngelaki et al. · American Journal of Obstetrics and Gynecology · 2015 · 626 citations

Medicine, Maternal Health, Obstetrics +16

A High Admission Syndecan-1 Level, A Marker of Endothelial Glycocalyx Degradation, Is Associated With Inflammation, Protein C Depletion, Fibrinolysis, and Increased Mortality in Trauma Patients

Pär I. Johansson, Jakob Stensballe, Lars S. Rasmussen et al. · Annals of Surgery · 2011 · 544 citations

Medicine, Clinical Sciences, Pathology +15